The biochemistry and pathophysiology of the contact system of plasma.
D000818:Animals; D000936:Antigen-Antibody Complex / Q000502:physiology; D000990:Antithrombin III / Q000502:physiology; D001485:Basement Membrane / Q000502:physiology; D001777:Blood Coagulation / Q000187:drug effects; D001798:Blood Proteins / Q000502:physiology; D002417:Cattle; D003094:Collagen / Q000494:pharmacology; D003174:Complement C1 Inactivator Proteins / Q000502:physiology; D005172:Factor XI / Q000032:analysis / Q000037:antagonists & inhibitors / Q000276:immunology; D005174:Factor XII / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D007704:Kininogens / Q000032:analysis / Q000502:physiology; D007962:Leukocytes / Q000502:physiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D010314:Partial Thromboplastin Time; D011288:Prekallikrein / Q000032:analysis / Q000502:physiology; D011485:Protein Binding; D011817:Rabbits; D013433:Sulfoglycosphingolipids / Q000494:pharmacology; D014527:Uric Acid / Q000494:pharmacology; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins / Q000502:physiology
D000936:Antigen-Antibody Complex; D001798:Blood Proteins; D003174:Complement C1 Inactivator Proteins; D007704:Kininogens; D008070:Lipopolysaccharides; D013433:Sulfoglycosphingolipids; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D014527:Uric Acid; D000990:Antithrombin III; D005174:Factor XII; D003094:Collagen; D005172:Factor XI; D011288:Prekallikrein